Many myeloma mouse genetically engineered models have focused on the dysregulation (overexpression or knock-out) of a particular gene or pathway, most notably, the dysregulation of MYC or BCL2[46,47], as well as the earlier spontaneous 5T models that have M spikes and develop bone lesions[48]. This evidence concerns the gene BCL2 and plasma cell myeloma.